Atezolizumab plus stereotactic ablative therapy for medically inoperable patients with early-stage non-small cell lung cancer.

Karen Kelly, Arta M. Monjazeb, Amin Mirhadi et al.|Journal of Clinical Oncology|2020

Cited by 12